Improving Venous Thromboembolism Prophylaxis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01304108|
Recruitment Status : Completed
First Posted : February 25, 2011
Last Update Posted : February 25, 2011
|Condition or disease||Intervention/treatment||Phase|
|Venous Thromboembolism Delivery of Health Care Quality Improvement||Other: VTE-P Tollgate Other: BLAZE Pop up Other: Usual Care||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||3000 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Spreading and Improving DVT Prophylaxis at Mayo Clinic (DVT-P-Spread)|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||May 2010|
|Actual Study Completion Date :||May 2010|
Experimental: Order Set
Insertion of VTE-P Order Set "tollgate" in all active admission and transfer orders.
Other: VTE-P Tollgate
Add VTE-P tollgate order set that requires a decision regarding VTE-P for every patient admitted or transferred in our hospital system
Experimental: Clinical Decision Support Pop-up
Deploy rules-based pop-up that reminds ordering clinicians when patients do not have an active VTE-P plan.
Other: BLAZE Pop up
Develop and deploy a rules-based popup that reminds prescribers interfacing with the orders system when a patient does not have an active VTE-P plan.
Active Comparator: Usual Care
Usual care, without the experimental additions
Other: Usual Care
No addition to the baseline system for care
- % of in patients with an appropriate VTE prophylaxis plan [ Time Frame: Baseline to 1 month ]The investigators will measure the number of patients in a statistically valid random sample of hospitalized patients who have a VTE-prophylaxis plan consistent with current recommendations.
- Clinically significant complications of VTE-P anticoagulant therapy [ Time Frame: baseline to 1 month ]The investigators will determine the rate of bleeding complications in inpatients using a statistically valid random sample of hospitalized patients. The investigators will also determine the rate of procedure delays due to VTE-P related anticoagulation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01304108
|United States, Minnesota|
|Mayo Clinic in Rochester|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Timothy Morgenthaler, MD||Mayo Clinic|